Detalles de la búsqueda
1.
Binding of Cu2+ to Aß1-29 causes aggregation and toxicity in SH-SY5Y cells.
Biochem Biophys Res Commun
; 534: 617-623, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33208229
2.
Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study.
Lupus
; 30(7): 1146-1153, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33794706
3.
Functional complementation reveals that 9 of the 13 human V-ATPase subunits can functionally substitute for their yeast orthologs.
J Biol Chem
; 294(20): 8273-8285, 2019 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30952699
4.
A disintegrin and metalloproteinase (ADAM)-10 as a predictive factor for tocilizumab effectiveness in rheumatoid arthritis.
Mod Rheumatol
; 27(5): 782-786, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27846745
5.
V-ATPase-dependent luminal acidification is required for endocytic recycling of a yeast cell wall stress sensor, Wsc1p.
Biochem Biophys Res Commun
; 443(2): 549-55, 2014 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24326069
6.
Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota.
Nat Commun
; 13(1): 4477, 2022 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35982037
7.
Factors in the awareness of depression, focusing on perceptual dissimilarities between PCPs and patients: an exploratory and qualitative research.
Hokkaido Igaku Zasshi
; 86(2): 79-83, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21485321
8.
Serum anti-Müllerian hormone levels in women with rheumatoid arthritis during tumor necrosis factor-α inhibitor treatment: Exploratory research.
Obstet Med
; 12(4): 186-189, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31853259
9.
Predictor of the Simplified Disease Activity Index 50 (SDAI 50) at Month 3 of bDMARD Treatment in Patients with Long-Established Rheumatoid Arthritis.
Open Rheumatol J
; 11: 106-112, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29290847
10.
Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment.
Intern Med
; 56(17): 2271-2275, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28794381
11.
Comparative Study of Infliximab Therapy and Methotrexate Monotherapy to Improve the Clinical Effect in Rheumatoid Arthritis Patients.
Intern Med
; 55(18): 2581-5, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27629950
12.
Human Lipocalin-Type Prostaglandin D Synthase-Based Drug Delivery System for Poorly Water-Soluble Anti-Cancer Drug SN-38.
PLoS One
; 10(11): e0142206, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26529243
13.
Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State.
Open Rheumatol J
; 9: 51-6, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26312106
14.
Influence of renal complications on the efficacy and adverse events of tacrolimus combination therapy in patients with systemic lupus erythematosus (SLE) during a maintenance phase: a single-centre, prospective study.
Lupus Sci Med
; 2(1): e000091, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26056606
15.
Combined infliximab and methotrexate treatment improves the depressive state in rheumatoid arthritis patients more effectively than methotrexate alone.
Eur J Rheumatol
; 1(4): 147-149, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27708901
Resultados
1 -
15
de 15
1
Próxima >
>>